For media enquiries, please contact our Media Relations team by email at IpsenMediaRelations(at)ipsen(dot)com.
Media contacts: https://www.ipsen.com/media-contacts/
Press Releases
ImCheck Therapeutics obtains 1M€ from Bpifrance to contribute to the development of a novel therapeutic antibody in immuno-oncology
| Financial & Business
First non-dilutive funding received by ImCheck following its initial fundraising of 20 M€ in May 2017
ImCheck Therapeutics raises €20 Million and appoints its CEO
| Financial & Business
Emerging leader in immuno-oncology accelerates its development programs and prepares for entry into the clinic